Urine colorimetry to detect Low rifampin exposure during tuberculosis therapy: a proof-of-concept study

BACKGROUND: The cost and complexity of current approaches to therapeutic drug monitoring during tuberculosis (TB) therapy limits widespread use in areas of greatest need. We sought to determine whether urine colorimetry could have a novel application as a form of therapeutic drug monitoring during a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zentner, Isaac, Schlecht, Hans P., Khensouvann, Lorna, Tamuhla, Neo, Kutzler, Michele, Ivaturi, Vijay, Pasipanodya, Jotam G., Gumbo, Tawanda, Peloquin, Charles A., Bisson, Gregory P., Vinnard, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888587/
https://www.ncbi.nlm.nih.gov/pubmed/27250739
http://dx.doi.org/10.1186/s12879-016-1576-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888587/
https://www.ncbi.nlm.nih.gov/pubmed/27250739
http://dx.doi.org/10.1186/s12879-016-1576-1

Ejemplares similares